박
박한수 Directeur Exécutif
Other M
Discover the complete record of transactions filed by 박한수, Directeur Exécutif. Director active across 2 companies, notably 비보존 제약. In total, 93 disclosures have been published. Activity tracked since 5 March 2026. The latest transaction was disclosed on 30 April 2026 (Purchase). Regulator: DART (FSS). The full history is openly available.
Declarations 93 total
● Executives · 26 May 2026 (filed) · 비보존 제약 277,778 shares DART:20260526000366 ● - · Executives · 30 Apr 2026 · 비보존 제약 277,778 shares @ ₩9,000.00 0.0007% mcap 100.0% of flow Share DART:20260507000560 Ideal exit: 25 Jan 2027 (T+270) ● 상무 · Executives · 15 Apr 2026 (filed) · 비보존 제약 Share DART:20260415000508 Ideal exit: 10 Jan 2027 (T+270) ● 사내이사 · Executives · 15 Apr 2026 (filed) · 비보존 제약 Share DART:20260415000525 Ideal exit: 10 Jan 2027 (T+270) ● Executives · 9 Apr 2026 (filed) · 비보존 제약 180,954 shares DART:20260409002937 ● 사내이사 · Executives · 6 Apr 2026 (filed) · 비보존 제약 Share DART:20260406003902 Ideal exit: 1 Jan 2027 (T+270) ● - · Executives · 31 Mar 2026 · 비보존 제약 180,954 shares @ ₩9,000.00 0.0005% mcap 100.0% of flow Share DART:20260403003027 Ideal exit: 26 Dec 2026 (T+270) ● Executives · 31 Mar 2026 (filed) · 비보존 제약 ● Executives · 23 Mar 2026 (filed) · 비보존 제약 ● 상무 · Executives · 5 Mar 2026 · 비보존 제약 938 shares @ ₩3,065.00 0.0000% mcap 100.0% of flow Share DART:20260312000131 Ideal exit: 30 Nov 2026 (T+270) ● - · Executives · 5 Mar 2026 · 비보존 제약 1,067,850 shares @ ₩3,065.00 0.0005% mcap 100.0% of flow Share DART:20260312000892 Ideal exit: 30 Nov 2026 (T+270) ● Executives · 12 Mar 2026 (filed) · 비보존 제약 2,218 shares DART:20260312001007 Ideal exit: 7 Dec 2026 (T+270) ● 이사 · Executives · 5 Mar 2026 · 비보존 제약 6,694 shares @ ₩3,065.00 0.0000% mcap 100.0% of flow Share DART:20260312000416 Ideal exit: 30 Nov 2026 (T+270) ● 사내이사 · Executives · 5 Mar 2026 · 비보존 제약 30,232 shares @ ₩3,065.00 0.0000% mcap 100.0% of flow Share DART:20260312000316 Ideal exit: 30 Nov 2026 (T+270) ● 상무 · Executives · 5 Mar 2026 · 비보존 제약 3,531 shares @ ₩3,065.00 0.0000% mcap 100.0% of flow Share DART:20260312001284 Ideal exit: 30 Nov 2026 (T+270) ● 이사 · Executives · 5 Mar 2026 · 비보존 제약 452 shares @ ₩3,065.00 0.0000% mcap 100.0% of flow Share DART:20260312000032 Ideal exit: 30 Nov 2026 (T+270) ● 상무 · Executives · 5 Mar 2026 · 비보존 제약 4,540 shares @ ₩3,065.00 0.0000% mcap 100.0% of flow Share DART:20260311003296 Ideal exit: 30 Nov 2026 (T+270) ● 상무 · Executives · 5 Mar 2026 · 비보존 제약 1,419 shares @ ₩3,065.00 0.0000% mcap 100.0% of flow Share DART:20260311003307 Ideal exit: 30 Nov 2026 (T+270) ● 대표이사 · Executives · 5 Mar 2026 · 비보존 제약 19,897 shares @ ₩3,065.00 0.0000% mcap 100.0% of flow Share DART:20260311003174 Ideal exit: 30 Nov 2026 (T+270) ● 상무 · Executives · 12 Feb 2026 (filed) · 비보존 제약 Share DART:20260212000183 Ideal exit: 9 Nov 2026 (T+270) ● Executives · 6 Feb 2026 (filed) · 비보존 제약 3,216,188 shares DART:20260206001696 ● - · Executives · 6 Feb 2026 (filed) · 비보존 제약 Share DART:20260206000730 ● - · Executives · 6 Feb 2026 (filed) · 비보존 제약 Share DART:20260206001570 ● 대표이사 · Executives · 2 Feb 2026 (filed) · 비보존 제약 Share DART:20260202000458 Ideal exit: 30 Oct 2026 (T+270) ● 상무 · Executives · 30 Jan 2026 (filed) · 비보존 제약 Share DART:20260130000418 Ideal exit: 27 Oct 2026 (T+270) 25 of 93 declarations
Load more (68 remaining) About 박한수 Park Han-soo is an Executive Director at Bivision Pharmaceuticals. In this role, he oversees operations and participates in implementing the company’s strategy. His experience in the pharmaceutical sector enables him to guide the company towards sustainable growth and enhance the services offered to clients.